Immunohistochemical analysis of CD155 expression in triple-negative breast cancer patients.

Yoshikawa, Katsuhiro; Ishida, Mitsuaki; Yanai, Hirotsugu; Tsuta, Koji; Sekimoto, Mitsugu; Sugie, Tomoharu

Yoshikawa, Katsuhiro; Ishida, Mitsuaki; Yanai, Hirotsugu; Tsuta, Koji; Sekimoto, Mitsugu; Sugie, Tomoharu.

Affiliation

Yoshikawa K; Department of Pathology and Clinical Laboratory, Kansai Medical University, Osaka, Japan.
Ishida M; Department of Surgery, Kansai Medical University, Osaka, Japan.
Yanai H; Department of Pathology and Clinical Laboratory, Kansai Medical University, Osaka, Japan.
Tsuta K; Department of Surgery, Kansai Medical University, Osaka, Japan.
Sekimoto M; Department of Pathology and Clinical Laboratory, Kansai Medical University, Osaka, Japan.
Sugie T; Department of Surgery, Kansai Medical University, Osaka, Japan.

PLoS One ; 16(6): e0253176, 2021.

Article in En | MEDLINE | ID: mdl-34115802

Subject(s)

Receptors, Virus/metabolism; Triple Negative Breast Neoplasms/pathology; Adult; Aged; Aged, 80 and over; B7-H1 Antigen/metabolism; Breast/metabolism; Breast/pathology; Disease-Free Survival; Female; Humans; Middle Aged; Neoplasm Staging; Survival Analysis; Triple Negative Breast Neoplasms/metabolism; Triple Negative Breast Neoplasms/mortality

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Receptors, Virus / Triple Negative Breast Neoplasms Type of study: Prognostic_studies Limits: Adult / Aged / Aged80 / Female / Humans / Middle aged Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2021 Document type: Article Affiliation country: Japan Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google